Compare Carvana Co (CVNA) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Carvana Co vs Tempus AI — how do they compare? Carvana Co trades at $63.55 (market cap $69.07B), while Tempus AI trades at $70 (market cap $12.77B). The key difference: Carvana Co is far larger — about 5.4× Tempus AI's market cap, and Tempus AI is trading nearer its 52-week high, Carvana Co nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Carvana Co for 28 Days and Tempus AI for 22 Days on average.
| CVNA | TEM | |
|---|---|---|
Market Cap | $69.07B | $12.77B |
Volume | 6,556,641 | 8,980,490 |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $95.69 | $99.28 |
52-Week Low | $56.27 | $41.55 |
Typical Hold Time | 28 Days | 22 Days |
Enterprise Value | $71.55B | $13.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Carvana (CVNA) trades at $63.21, down 1.02% on the day, with a bearish technical signal from moving averages. The company reported strong fundamentals, including Q2 2026 EPS of $0.42 beating estimates, revenue growth to $20.32B in 2025, and a net income margin of 6.26%. Recent news highlights robust sales performance, with Jefferies noting September unit sales 40% above estimates. Cash flow trends show positive operational growth, though high debt levels and an elevated EV/EBITDA of 503.9 pose concerns.
The outlook for CVNA is mixed; strong revenue growth and operational improvements support upside potential, with a consensus price target of $84.07 implying significant appreciation. However, risks include high valuation multiples, substantial long-term debt of $5.26B, and bearish technical indicators. Investors should weigh robust earnings beats against volatility and leverage concerns.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Carvana Co
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage.
Read more on CVNA →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
